Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ILKAP | Human | 1,2-dimethylhydrazine | increases expression | ISO | Ilkap (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ILKAP mRNA | CTD | PMID:22206623 | ILKAP | Human | 17alpha-ethynylestradiol | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of ILKAP mRNA | CTD | PMID:17557909 | ILKAP | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ilkap (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ILKAP mRNA | CTD | PMID:21570461 | ILKAP | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ILKAP mRNA | CTD | PMID:34747641 | ILKAP | Human | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of ILKAP mRNA | CTD | PMID:19162173 | ILKAP | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ILKAP mRNA | CTD | PMID:17218384 | ILKAP | Human | ammonium chloride | affects expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ILKAP mRNA | CTD | PMID:16483693 | ILKAP | Human | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ILKAP protein] | CTD | PMID:26598702 | ILKAP | Human | Benoxacor | increases expression | ISO | Ilkap (Mus musculus) | 6480464 | benoxacor results in increased expression of ILKAP mRNA | CTD | PMID:34850242 | ILKAP | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ILKAP promoter | CTD | PMID:27901495 | ILKAP | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ILKAP protein | CTD | PMID:33278487 | ILKAP | Human | bisphenol A | increases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ILKAP mRNA | CTD | PMID:25181051 | ILKAP | Human | bisphenol A | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ILKAP mRNA | CTD | PMID:30816183 | ILKAP | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ILKAP mRNA | CTD | PMID:29275510 | ILKAP | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of ILKAP protein | CTD | PMID:35688186 | ILKAP | Human | carbon nanotube | decreases expression | ISO | Ilkap (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of ILKAP mRNA | CTD | PMID:25554681 | ILKAP | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ILKAP gene] | CTD | PMID:28238834 | ILKAP | Human | clozapine | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Clozapine results in decreased expression of ILKAP mRNA | CTD | PMID:15860345 | ILKAP | Human | copper atom | increases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Copper results in increased expression of ILKAP mRNA | CTD | PMID:30556269 | ILKAP | Human | copper(0) | increases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Copper results in increased expression of ILKAP mRNA | CTD | PMID:30556269 | ILKAP | Human | crocidolite asbestos | decreases expression | ISO | Ilkap (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of ILKAP mRNA | CTD | PMID:29279043 | ILKAP | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ILKAP mRNA | CTD | PMID:20106945 | ILKAP | Human | daunorubicin | affects response to substance | EXP | | 6480464 | ILKAP affects the susceptibility to Daunorubicin | CTD | PMID:17545624 | ILKAP | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ILKAP protein] | CTD | PMID:26598702 | ILKAP | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ILKAP protein | CTD | PMID:23301498 | ILKAP | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ILKAP protein | CTD | PMID:37730182 | ILKAP | Human | haloperidol | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Haloperidol results in decreased expression of ILKAP mRNA | CTD | PMID:15860345 | ILKAP | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ILKAP protein | CTD | PMID:32959892 | ILKAP | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Ilkap (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ILKAP protein | CTD | PMID:26558463 | ILKAP | Human | N-nitrosodiethylamine | multiple interactions | ISO | Ilkap (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ILKAP mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ILKAP promoter | CTD | PMID:25374375 | ILKAP | Human | nickel dichloride | affects expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of ILKAP mRNA | CTD | PMID:22546817 | ILKAP | Human | phenobarbital | multiple interactions | ISO | Ilkap (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ILKAP mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ILKAP promoter | CTD | PMID:25374375 | ILKAP | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ILKAP mRNA | CTD | PMID:23557933 | ILKAP | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of ILKAP mRNA | CTD | PMID:25895662 | ILKAP | Human | Soman | decreases expression | ISO | Ilkap (Rattus norvegicus) | 6480464 | Soman results in decreased expression of ILKAP mRNA | CTD | PMID:19281266 | ILKAP | Human | triptonide | decreases expression | ISO | Ilkap (Mus musculus) | 6480464 | triptonide results in decreased expression of ILKAP mRNA | CTD | PMID:33045310 | ILKAP | Human | valproic acid | decreases expression | ISO | Ilkap (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of ILKAP mRNA | CTD | PMID:21427059 | ILKAP | Human | valproic acid | affects expression | ISO | Ilkap (Mus musculus) | 6480464 | Valproic Acid affects the expression of ILKAP mRNA | CTD | PMID:17963808 | ILKAP | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ILKAP mRNA | CTD | PMID:23179753 | ILKAP | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ILKAP mRNA | CTD | PMID:25979313 | |